Reference | Patient sample and time frame | Sampling strategy* | Specialty | Events identified | Automated event dataset sample size | Comparison event dataset sample size |
Field-defined | ||||||
Nebeker et al18 | Adults 2001 and 2003 | Random | Unknown | Adverse drug events | 3987 admissions | 3987 admissions |
Zhan et al17 | Medicare benefic. 2002 to 2004 | Random | General Surgery | Adverse event: specifically postoperative deep venous thrombosis and/or pulmonary embolism | 20 868 hospital discharges identified as surgical patients | 20 868 hospital discharges identified as surgical patients |
Brossette et al44 | Unknown 1–3 Dec 2003 and 26–29 Apr 2004 | Sequential | Unknown | Infection | 907 admissions | 907 admissions |
Hougland et al30 | Adults 1 Jan 2001 to 31 Dec 2001 | Random, Flagged sample (from records with at least one flagged adverse drug event code) | Unknown | Adverse drug events | 3103 inpatients: 1961 random, 1142 flagged | Unknown |
Polancich et al15 | Unknown | Unknown | Unknown | Hospital acquired decubitus ulcers | Unknown | 123 charts from patients with PSI-identified decubitus ulcers |
Dormann et al26 | Adults 1 Sept 2000 to 28 Feb 2001 | Sequential | Gastroenterology | Adverse drug events | 474 admissions of 377 patients; 109 ADEs | 474 admissions of 377 patients; 109 adverse drug events |
Trick et al20 | Adults 1 Sept 2001 to 28 Feb 2002 | Sequential | Unknown | Infection | 135 positive blood cultures | 144 positive blood cultures |
Levy et al23 | All age groups 1 Apr 1997 to 31 May 1997 | Sequential | General Medical | Adverse drug events | 199 admissions (192 patients) | 199 admissions |
Azaz-Livshits et al22 | All age groups 1 Apr 1995 to 31 May 1995 | Sequential | General Medical | Adverse drug events | 153 admissions | 153 admissions |
Jha et al32 | Adults 1 Oct 1994 to 31 May 1995 | Sequential | MICU, SICU, General Medical, General Surgical | Adverse drug events | 21 964 patient-days | 21 964 patient-days |
NLP | ||||||
Penz et al47 | Adults 1 Jun 1999 to 31 Dec 2004 | Sequential | MICU, SICU and other (placement of CVC) | Adverse events related to central venous catheter placement | 316 patient records | 40 patients records (10 very low probability† records, 30 high probability) |
Forster et al34 | Adults FY 2002 | Random | General Medical, General Surgical | Adverse event | 245 patients | 245 patients |
Melton and Hripcsak48 | Unknown 1996–2000 | Random (charts), Sequential (electronic discharge summaries) | Unknown | Adverse events: specifically 45 NYPORTS event types | 1000 charts, 57 422 electronic discharge summaries | 1000 charts |
Murff et al33 | Adults 1 Jan 2000 to 30 Jun 2000 | Random (Cohort 1), Sequential (Cohort 2) | General Medical, Medicine subspecialties | Adverse drug events, adverse events, diagnostic errors, operative complications, falls | Cohort 1: 424 admissions. Cohort 2: 2826 admissions | Cohort 1: 295 Cohort 2: 145 Complex sampling/subsampling and manual review process |
↵* Sampling strategy refers to the method by which charts were chosen to be screened by the automated tool. Unless specifically noted, the same sampling strategy also applies to the gold standard method.
↵† A scoring system was developed by the authors to reflect the probability of the adverse event in question relating to the central venous catheter placement. This system is described in the text and in table 1 of the paper.
CVC, central venous catheter; MICU, Medical Intensive Care Unit; NYPORTS, New York Patient Occurrence Reporting and Tracking System; PSI, patient safety indicators; SICU, Surgical Intensive Care Unit.